fda glp-1 news november 2025 Pipeline Update: - Prime Therapeutics GLP-1 Drugs and the Physiology

It has a shorter half-life, so effects may fade faster unless doses are maintained

FDX1 has the ability to directly interact with copper ions present in plaques, thereby triggering protein-induced toxic stress

Although a few people may experience temporary discomfort at the injection site, these symptoms are generally tolerable

Cannabinoids and the gastrointestinal tract

He was referred to the medical oncology department and started high-dose intravenous interferon -2b (20,000,000 international units [IU]/m2, five days per week) for one month, followed by subcutaneous injections (10,000,000IU/m2, three times per week)